AK Steel Holding Corp. (NYSE:AKS)‘s stock had its “outperform” rating reaffirmed by Zacks in a research note issued to investors on Tuesday, American Banking News reports. They currently have a $7.25 price objective on the stock. Zacks‘s price target would indicate a potential upside of 10.69% from the company’s current price. AK Steel Holding Corporation (NYSE:AKS) shares after opening at $6.51 on last trade day and at the end of the day closed at $6.70. Company price to sales ratio in past twelve months was calculated as 0.16 and price to cash ratio as 20.10. AK Steel Holding Corporation (NYSE:AKS) showed a positive weekly performance of 10.02%.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on corporate developments. Iclusig was re-launched in the U.S. in mid-January with all members of the commercial team in place. Through the first five weeks of commercialization, approximately 180 out of 305 patients from the single-patient IND program have transitioned to commercial supply. We anticipate that approximately 50 additional patients will transition by the end of this quarter. In Europe, we are selling Iclusig in Germany, the United Kingdom, France, Austria and the Netherlands. This year, we will expand commercialization of Iclusig to all of the major markets in Europe – 16 individual countries – based on staged achievement of pricing and reimbursement approvals in each country. We anticipate the majority of the remaining EU pricing approvals will occur in the second half of 2014. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares fell -0.73% in last trading session and ended the day on $8.13. ARIA return on equity ratio is recorded as -105.40% and its return on assets is -74.30%. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) yearly performance is -60.24%.
Newcastle Investment Corp. (NYSE:NCT) announced a dividend on Friday, March 14th, ARN reports. Shareholders of record on Tuesday, March 25th will be paid a dividend of 0.10 per share on Wednesday, April 30th. The ex-dividend date is Friday, March 21st. Newcastle Investment Corp. (NYSE:NCT) shares moved down -2.34% in last trading session and was closed at $4.59, while trading in range of $4.57 – $4.72. Newcastle Investment Corp. (NYSE:NCT) year to date (YTD) performance is -4.77%.
TheStreet Ratings team rates McEwen Mining Inc (NYSE:MUX) as a Hold with a ratings score of C-. McEwen Mining Inc (NYSE:MUX) weekly performance is -23.93%. On last trading day company shares ended up $2.67. McEwen Mining Inc (NYSE:MUX) distance from 50-day simple moving average (SMA50) is -2.77%. Analysts mean target price for the company is $3.90.
Leave a Reply